Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan
| Autor: | Hsieh, Szu-Min, Liu, Ming-Che, Chen, Yen-Hsu, Lee, Wen-Sen, Hwang, Shinn-Jang, Cheng, Shu-Hsing, Ko, Wen-Chien, Hwang, Kao-Pin, Wang, Ning-Chi, Lee, Yu-Lin, Lin, Yi-Ling, Shih, Shin-Ru, Huang, Chung-Guei, Liao, Chun-Che, Liang, Jian-Jong, Chang, Chih-Shin, Chen, Charles, Lien, Chia En, Tai, I-Chen, Lin, Tzou-Yien * |
|---|---|
| Zdroj: | In The Lancet Respiratory Medicine December 2021 9(12):1396-1406 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|